Skip to main content

REACH SVHC COMPLIANCE

The European Chemical Agency (ECHA) has current and future substances identified as Substances of Very High Concern (SVHC).

Once a substance is added to the SVHC Candidate List, the EU REACH Regulation imposes immediate obligations on manufacturers and importers to declare the substances if present.

Article 33(1) of the REACH Regulation states that manufacturers and importers of articles (products) are required to notify their customers of the presence of any Substances of Very High Concern (SVHC) in their products exceeding 0.1% by weight and provide instructions on safe use of the product.

Tox Regulatory Advisor offers SVHC consulting, and assessment services to assist companies determine the presence of SVHC substances in their products.

If a product contains any SVHC, Tox Regulatory Affairs can provide risk assessments to:

  • Identify whether products / articles contain any SVHC 
  • Identify other products in your portfolio that have the potential to pose a risk
  • Create a substitution strategy of SVHC and prepare a safe use instruction to fulfil the REACH requirements
  • Disclose the presence of SVHCs in products within 45 days upon request from consumers.

ABOUT US

Helping Companies Successfully Transition from Innovation to Regulated Healthcare and Product Safety

Founded in 2009, TOX Regulatory Advisor ApS is an independent consultancy specialising in Regulatory Affairs, Clinical Affairs, Quality Management and Toxicology.

For more than 15 years, we have supported organisations across the medical device, in vitro diagnostic (IVD), pharmaceutical, chemical and cosmetic sectors in navigating complex regulatory, scientific and quality requirements throughout the entire product lifecycle.

Our expertise spans Europe, North America, Asia, Latin America, Africa and the BRICS countries, supporting organisations from early product development through regulatory approval, market access and post-market activities.

As healthcare continues to evolve through Artificial Intelligence (AI), connected technologies and digital health solutions, regulatory expectations are evolving as well.

Today, our expertise has expanded to support organisations developing AI-enabled medical devices and Software as a Medical Device (SaMD), helping bridge the requirements of the EU Medical Device Regulation (EU MDR 2017/745), the EU Artificial Intelligence Act (EU AI Act 2024/1689) and the General Data Protection Regulation (GDPR).

Successfully bringing AI-enabled medical devices to market requires more than software development alone. It requires the integration of regulatory affairs, quality management, risk management, design controls, validation, clinical affairs, human factors, data governance and lifecycle management into a coherent development strategy.

At Tox Regulatory Advisor, we help organisations bridge these technical, clinical and regulatory requirements to support the development of safe, effective and compliant healthcare products.

Alongside our expertise in AI-enabled medical devices, we continue to support manufacturers of medical devices, IVDs, pharmaceuticals, chemicals and cosmetic products through practical scientific, regulatory and quality solutions tailored to their business needs.

Our Areas of Expertise

AI-Enabled Medical Devices & Digital Health

Supporting software companies, digital health innovators and MedTech manufacturers with:

  • EU AI Act implementation and AI Medical Device Readiness

  • Regulatory Strategy and AI Risk Management

  • Clinical Validation, Human Factors & Usability Engineering &AI Governance

  • Design Controls & Design Assurance

  • Post-Market Surveillance, Quality Management Systems & Technical Documentation

  • Executive Advisory, Workshops and Team Training

Medical Devices & In Vitro Diagnostics (IVDs)

Supporting manufacturers throughout the product lifecycle with:

  • Regulatory Affairs, Clinical Affairs and Biological evaluation/biocompatibility

  • Design Controls & Design Assurance

  • Design Verification & Validation

  • Risk Management & Technical Documentation

  • Quality Management Systems & Post-Market Support

  • Standards Compliance & Global Market Access

Pharmaceuticals, Chemicals & Toxicology

Supporting organisations with:

  • Toxicological Risk Assessment and Chemical Regulatory Compliance

  • Scientific and Regulatory Strategy &Product Stewardship

  • Safety Documentation &Regulatory Support

Cosmetic Safety & Product Development

Helping organisations develop safe, effective and compliant cosmetic products through:

  • Cosmetic Formulation, Cosmetic Safety Assessments &Toxicological Risk Assessment

  • Ingredient Evaluation, Regulatory Compliance & Product Development Support

Our Approach

Our role extends beyond helping organisations comply with regulations.

We help our clients make informed development decisions by integrating science, engineering, clinical thinking, quality management and regulatory strategy from the earliest stages of product development through market access and lifecycle management.

Whether supporting AI-enabled medical devices, medical devices, IVDs, pharmaceuticals, chemicals or cosmetic products, our objective remains the same:

Helping organisations reduce regulatory uncertainty, strengthen product development and bring safe, effective and compliant products to market with confidence.

Turning innovation into products prepared for regulated healthcare and global markets.

Further information regarding services, expertise and how our experience can support your business?

Please contact us at: